United States - English - NLM (National Library of Medicine)

sanja pharmaceuticals company - carboplatin (unii: bg3f62ond5) (carboplatin - unii:bg3f62ond5) - carboplatin 50 mg in 5 ml - initial treatment of advanced ovarian carcinoma carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. one established combination regimen consists of carboplatin injection and cyclophosphamide. two randomized controlled studies conducted by the ncic and swog with carboplatin, usp vs. cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see clinical studies ). there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long term survival (≥ 3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor < 2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. secondary treatment of advanced ovarian carcinoma carboplatin injection is indicated for the palliative treatment of pati

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - carboplatin (unii: bg3f62ond5) (carboplatin - unii:bg3f62ond5) - carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. one established combination regimen consists of carboplatin and cyclophosphamide. two randomized controlled studies conducted by the ncic and swog with carboplatin versus  cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see clinical studies ). there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥ 3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor < 2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. carboplatin injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously t

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - clethodim; liquid hydrocarbon; liquid hydrocarbon; liquid hydrocarbon - emulsifiable concentrate - clethodim cyclohexanediones active 240.0 g/l; liquid hydrocarbon solvent other 663.0 g/l; liquid hydrocarbon solvent other 606.0 g/l; liquid hydrocarbon solvent other 643.0 g/l - herbicide - adzuki bean | beetroot | broad bean | cabbage | canola | celery | chickpea | clover pasture | cotton | faba bean | field pea | f - annual phalaris | annual ryegrass | barley grass | barnyard or water grass | blown grass | brome grass | crowsfoot grass | feathertop rhodes grass | johnson grass - seedling | lesser canary grass | liverseed or urochloa grass | paradoxa grass | red sprangletop grass | silver grass (v.bromoides) - suppression | summer or crab grass | volunteer barley | volunteer oat | volunteer sorghum | volunteer wheat | wild oat | winter grass | annual blue grass | annual canary grass | annual phalaris | annual poa | annual summer grass | barnyard grass | bromus diandrus | bromus rigidus | canary grass | common oats | crab grass | goose grass | h. hexastichon | hairy rhodes grass | liverseed grass | native rhodes grass | sweet summer grass | triticum aestivum | woollytop rhodes grass

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - carboplatin 10 mg/ml;  ;   - solution for injection - 10 mg/ml - active: carboplatin 10 mg/ml     excipient: nitrogen water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk limited - carboplatin - concentrate for soln for inf - 10 mg/ml - carboplatin

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk limited - carboplatin - concentrate for soln for inf - 10 mg/ml - platinum compounds

United States - English - NLM (National Library of Medicine)

sandoz inc - carboplatin (unii: bg3f62ond5) (carboplatin - unii:bg3f62ond5) - carboplatin 10 mg in 1 ml - carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. one established combination regimen consists of carboplatin and cyclophosphamide. two randomized controlled studies conducted by the ncic and swog with carboplatin versus cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see clinical studies ). there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor <2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. carboplatin is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with c

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - carboplatin 10 mg/ml;   - concentrate for injection - 10 mg/ml - active: carboplatin 10 mg/ml   excipient: water for injection - - treatment of advanced stage ovarian cancer of epithelial origin - small cell lung carcinoma - carcinoma of the head and neck - carcinoma of the testis - paediatric cerebral tumours - soft tissue sarcoma - neuroblastoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - carboplatin - concentrate for solution for infusion - 10 milligram(s)/millilitre - platinum compounds; carboplatin

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - carboplatin - concentrate for solution for infusion - 10 milligram(s)/millilitre - platinum compounds; carboplatin